SEC Form 4 · accession 0001140361-15-001483
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tae Heum Jeong
Officer — Chief Financial Officer
Period of report
Jan 8, 2015
Accepted (ET)
Jan 12, 2015 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001228627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2015 | M | 78,782 | $0.80 | A | 583,782 | D | |
| Common StockF2 | Jan 8, 2015 | S | 78,782 | $0.9004 | D | 505,000 | D | |
| Common Stock | Jan 9, 2015 | M | 188,690 | $0.80 | A | 693,690 | D | |
| Common StockF3 | Jan 9, 2015 | S | 188,690 | $0.9153 | D | 505,000 | D | |
| Common Stock | Jan 12, 2015 | M | 49,800 | $0.80 | A | 554,800 | D | |
| Common StockF4 | Jan 12, 2015 | S | 49,800 | $0.9135 | D | 505,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F5 | $0.80 | Jan 8, 2015 | M | 78,782 | D | — | Jan 20, 2015 | Common Stock | 78,782 | 421,218 | D |
| Stock Option (right to purchase)F5 | $0.80 | Jan 9, 2015 | M | 188,690 | D | — | Jan 20, 2015 | Common Stock | 188,690 | 232,528 | D |
| Stock Option (right to purchase)F5 | $0.80 | Jan 12, 2015 | M | 49,800 | D | — | Jan 20, 2015 | Common Stock | 49,800 | 182,728 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price of $0.9004 per share represents a weighted average of sales prices from $0.90 to $0.9088 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The price of $0.9153 per share represents a weighted average of sales prices from $0.90 to $0.945 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The price of $0.9135 per share represents a weighted average of sales prices from $0.90 to $0.9325 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5Options vested and became exercisable based on the following schedule: 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.